Drugs / Panlongqi Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03327012 | Nov 2017 → Mar 2019 | osteoarthritis, knee | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panlongqi Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03327012 ↗ |
| Route | Oral | “Panlongqi Tablet:1.2g,3times a day, oral, for 4 weeks.” NCT03327012 ↗ |